ThermoGenesis (THMO) Stock Forecast, Price Target & Predictions

THMO Stock Forecast

ThermoGenesis stock forecast is as follows:

ThermoGenesis Financial Forecast

ThermoGenesis Revenue Forecast

	Dec 24	Oct 24	Jul 24	Mar 24	Dec 23	Oct 23	Jul 23	Mar 23	Dec 22	Oct 22	Jul 22	Mar 22	Dec 21	Sep 21	Jun 21	Mar 21	Dec 20	Sep 20	Jun 20	Mar 20	Dec 19	Sep 19	Jun 19	Mar 19	Sep 18	Jun 18	Mar 16	Dec 15	Sep 15	Dec 14
Revenue	-	-	-	-	-	-	-	$2.57M	$2.68M	-	-	$2.66M	$2.42M	$3.16M	$2.20M	$1.52M	$1.95M	$2.35M	$2.24M	$3.20M	$1.72M	$4.06M	$4.30M	$2.96M	$3.11M	$2.00M	$2.83M	$3.29M	$2.82M	$4.64M
Avg Forecast	$4.60M	$4.30M	$4.10M	$3.80M	$3.60M	$3.10M	$4.57M	$2.80M	$2.90M	$3.00M	$5.80M	$5.60M	$3.40M	$3.06M	$1.99M	$2.66M	$2.60M	$3.88M	$5.80M	$5.40M	$7.09M	$4.80M	$3.40M	$3.10M	$2.59M	$8.00M	$91.97K	$4.61M	$1.91M	$4.35M
High Forecast	$4.60M	$4.30M	$4.10M	$3.80M	$3.60M	$3.10M	$4.57M	$2.80M	$2.90M	$3.00M	$5.80M	$5.60M	$3.40M	$3.06M	$1.99M	$2.66M	$2.60M	$3.88M	$5.80M	$5.40M	$7.09M	$4.80M	$3.40M	$3.10M	$3.11M	$9.60M	$110.37K	$5.53M	$2.29M	$5.22M
Low Forecast	$4.60M	$4.30M	$4.10M	$3.80M	$3.60M	$3.10M	$4.57M	$2.80M	$2.90M	$3.00M	$5.80M	$5.60M	$3.40M	$3.06M	$1.99M	$2.66M	$2.60M	$3.88M	$5.80M	$5.40M	$7.09M	$4.80M	$3.40M	$3.10M	$2.08M	$6.40M	$73.58K	$3.68M	$1.52M	$3.48M
# Analysts	-	-	1	1	1	-	-	-	-	-	-	-	-	-	-	13	13	7	7	9	8	6	10	6	14	18	15	15	11	20
Surprise %	-	-	-	-	-	-	-	0.92%	0.92%	-	-	0.48%	0.71%	1.03%	1.11%	0.57%	0.75%	0.61%	0.39%	0.59%	0.24%	0.85%	1.27%	0.96%	1.20%	0.25%	30.79%	0.72%	1.48%	1.07%

ThermoGenesis's average Quarter revenue forecast for Jul 23 based on 0 analysts is $4.57M, with a low forecast of $4.57M, and a high forecast of $4.57M. THMO's average Quarter revenue forecast represents a 77.57% increase compared to the company's last Quarter revenue of $2.57M (Mar 23).

ThermoGenesis EBITDA Forecast

	Dec 24	Oct 24	Jul 24	Mar 24	Dec 23	Oct 23	Jul 23	Mar 23	Dec 22	Oct 22	Jul 22	Mar 22	Dec 21	Sep 21	Jun 21	Mar 21	Dec 20	Sep 20	Jun 20	Mar 20	Dec 19	Sep 19	Jun 19	Mar 19	Sep 18	Jun 18	Mar 16	Dec 15	Sep 15	Dec 14
# Analysts	-	-	1	1	1	-	-	-	-	-	-	-	-	-	-	13	13	7	7	9	8	6	10	6	14	18	15	15	11	20
EBITDA	-	-	-	-	-	-	-	$-1.04M	$-1.27M	-	-	$-1.21M	$-1.20M	$-105.00K	$-2.99M	$-1.50M	$-1.25M	$-901.00K	$-5.00M	$-1.01M	$-3.06M	$-141.00K	$-74.00K	$-703.00K	$-1.78M	$-3.16M	$-2.52M	$-3.07M	$-4.09M	$-4.01M
Avg Forecast	$-2.61M	$-2.44M	$-2.33M	$-471.44K	$-2.04M	$-1.76M	$-2.59M	$-428.58K	$-1.65M	$-53.92K	$-3.29M	$-389.62K	$-396.71K	$-49.02K	$-2.64M	$-308.00K	$-1.70M	$-2.54M	$-461.45M	$-85.54M	$-4.64M	$-3.61M	$126.53K	$-527.00K	$-1.26M	$-59.84M	$-129.68M	$-424.29K	$-1.57M	$-2.52M
High Forecast	$-2.61M	$-2.44M	$-2.33M	$-377.15K	$-2.04M	$-1.76M	$-2.59M	$-342.87K	$-1.65M	$-43.13K	$-3.29M	$-311.70K	$-317.37K	$-39.21K	$-2.11M	$-246.40K	$-1.70M	$-2.54M	$-369.16M	$-68.43M	$-4.64M	$-2.89M	$151.84K	$-421.60K	$-1.01M	$-47.87M	$-103.74M	$-339.43K	$-1.26M	$-2.01M
Low Forecast	$-2.61M	$-2.44M	$-2.33M	$-565.73K	$-2.04M	$-1.76M	$-2.59M	$-514.30K	$-1.65M	$-64.70K	$-3.29M	$-467.54K	$-476.05K	$-58.82K	$-3.17M	$-369.60K	$-1.70M	$-2.54M	$-553.74M	$-102.65M	$-4.64M	$-4.34M	$101.23K	$-632.40K	$-1.52M	$-71.81M	$-155.61M	$-509.14K	$-1.89M	$-3.02M
Surprise %	-	-	-	-	-	-	-	2.43%	0.77%	-	-	3.11%	3.02%	2.14%	1.13%	4.86%	0.73%	0.35%	0.01%	0.01%	0.66%	0.04%	-0.58%	1.33%	1.41%	0.05%	0.02%	7.24%	2.60%	1.59%

undefined analysts predict THMO's average Quarter EBITDA for undefined to be $NaN, with a high of $NaN and a low of $NaN. This is NaN% lower than ThermoGenesis's previous annual EBITDA (undefined) of $NaN.

ThermoGenesis Net Income Forecast

	Dec 24	Oct 24	Jul 24	Mar 24	Dec 23	Oct 23	Jul 23	Mar 23	Dec 22	Oct 22	Jul 22	Mar 22	Dec 21	Sep 21	Jun 21	Mar 21	Dec 20	Sep 20	Jun 20	Mar 20	Dec 19	Sep 19	Jun 19	Mar 19	Sep 18	Jun 18	Mar 16	Dec 15	Sep 15	Dec 14
# Analysts	-	-	1	1	1	-	-	-	-	-	-	-	-	-	-	13	13	7	7	9	8	6	10	6	14	18	15	15	11	20
Net Income	-	-	-	-	-	-	-	$-13.13M	$-3.43M	-	-	$-1.91M	$-2.65M	$-1.77M	$-4.54M	$-2.41M	$-2.85M	$-2.46M	$-6.44M	$-4.60M	$-4.04M	$-2.28M	$-1.30M	$-1.87M	$-2.56M	$-27.16M	$-10.87M	$-624.00K	$-3.40M	$-4.39M
Avg Forecast	$120.77K	$80.52K	$80.52K	$-1.56M	$-40.26K	$-845.41K	$40.26K	$-1.42M	$-3.62M	$-1.10M	$3.62M	$-1.29M	$-750.14K	$-999.49K	$-4.19M	$-1.02M	$-25.91M	$-11.27M	$-602.50M	$-451.46M	$5.63M	$-9.24M	$-1.58M	$-1.87M	$-2.07M	$-53.98M	$-320.67M	$-802.28K	$-1.76M	$-2.73M
High Forecast	$120.77K	$80.52K	$80.52K	$-1.25M	$-40.26K	$-845.41K	$40.26K	$-1.14M	$-3.62M	$-879.55K	$3.62M	$-1.03M	$-600.11K	$-799.59K	$-3.35M	$-816.71K	$-25.91M	$-11.27M	$-482.00M	$-361.16M	$5.63M	$-7.39M	$-1.26M	$-1.50M	$-1.66M	$-43.19M	$-256.54M	$-641.83K	$-1.41M	$-2.19M
Low Forecast	$120.77K	$80.52K	$80.52K	$-1.88M	$-40.26K	$-845.41K	$40.26K	$-1.70M	$-3.62M	$-1.32M	$3.62M	$-1.55M	$-900.16K	$-1.20M	$-5.02M	$-1.23M	$-25.91M	$-11.27M	$-723.00M	$-541.75M	$5.63M	$-11.09M	$-1.89M	$-2.25M	$-2.49M	$-64.78M	$-384.80M	$-962.74K	$-2.11M	$-3.28M
Surprise %	-	-	-	-	-	-	-	9.24%	0.95%	-	-	1.48%	3.54%	1.77%	1.08%	2.36%	0.11%	0.22%	0.01%	0.01%	-0.72%	0.25%	0.82%	1.00%	1.24%	0.50%	0.03%	0.78%	1.93%	1.61%

ThermoGenesis's average Quarter net income forecast for undefined is $NaN, with a range of $NaN to $NaN. THMO's average Quarter net income forecast represents a NaN% decrease compared to the company's last Quarter net income of $NaN (undefined).

ThermoGenesis SG&A Forecast

	Dec 24	Oct 24	Jul 24	Mar 24	Dec 23	Oct 23	Jul 23	Mar 23	Dec 22	Oct 22	Jul 22	Mar 22	Dec 21	Sep 21	Jun 21	Mar 21	Dec 20	Sep 20	Jun 20	Mar 20	Dec 19	Sep 19	Jun 19	Mar 19	Sep 18	Jun 18	Mar 16	Dec 15	Sep 15	Dec 14
# Analysts	-	-	1	1	1	-	-	-	-	-	-	-	-	-	-	13	13	7	7	9	8	6	10	6	14	18	15	15	11	20
SG&A	-	-	-	-	-	-	-	$1.84M	$1.58M	-	-	$1.69M	$1.34M	$1.68M	$3.50M	$1.99M	$1.76M	$1.84M	$1.98M	$2.09M	$3.19M	$1.64M	$1.60M	$1.60M	$1.98M	$2.76M	$2.44M	$2.35M	$3.18M	$4.35M
Avg Forecast	$3.47M	$3.25M	$3.10M	$1.29M	$2.72M	$2.34M	$3.45M	$1.17M	$2.19M	$1.04M	$4.38M	$1.07M	$2.83M	$944.84K	$1.59M	$842.77K	$2.08M	$3.11M	$4.65M	$4.33M	$5.69M	$3.85M	$1.95M	$1.60M	$1.58M	$5.58M	$73.73K	$3.02M	$1.65M	$2.72M
High Forecast	$3.47M	$3.25M	$3.10M	$1.55M	$2.72M	$2.34M	$3.45M	$1.41M	$2.19M	$1.25M	$4.38M	$1.28M	$3.39M	$1.13M	$1.59M	$1.01M	$2.08M	$3.11M	$4.65M	$4.33M	$5.69M	$3.85M	$2.34M	$1.92M	$1.90M	$6.70M	$88.47K	$3.63M	$1.98M	$3.26M
Low Forecast	$3.47M	$3.25M	$3.10M	$1.03M	$2.72M	$2.34M	$3.45M	$938.17K	$2.19M	$831.46K	$4.38M	$852.88K	$2.26M	$755.87K	$1.59M	$674.22K	$2.08M	$3.11M	$4.65M	$4.33M	$5.69M	$3.85M	$1.56M	$1.28M	$1.27M	$4.47M	$58.98K	$2.42M	$1.32M	$2.18M
Surprise %	-	-	-	-	-	-	-	1.57%	0.72%	-	-	1.59%	0.48%	1.77%	2.20%	2.36%	0.85%	0.59%	0.43%	0.48%	0.56%	0.43%	0.82%	1.00%	1.25%	0.49%	33.11%	0.78%	1.93%	1.60%

ThermoGenesis's average Quarter SG&A projection for Jul 23 is $3.45M, based on 0 Wall Street analysts, with a range of $3.45M to $3.45M. The forecast indicates a 87.00% rise compared to THMO last annual SG&A of $1.84M (Mar 23).

ThermoGenesis EPS Forecast

	Dec 24	Oct 24	Jul 24	Mar 24	Dec 23	Oct 23	Jul 23	Mar 23	Dec 22	Oct 22	Jul 22	Mar 22	Dec 21	Sep 21	Jun 21	Mar 21	Dec 20	Sep 20	Jun 20	Mar 20	Dec 19	Sep 19	Jun 19	Mar 19	Sep 18	Jun 18	Mar 16	Dec 15	Sep 15	Dec 14
# Analysts	-	-	1	1	1	-	-	-	-	-	-	-	-	-	-	13	13	7	7	9	8	6	10	6	14	18	15	15	11	20
EPS	-	-	-	-	-	-	-	$-10.50	$-6.23	-	-	$-6.99	$-10.03	$-6.70	$-17.15	$-6.92	$-11.20	$-16.51	$-45.87	$-35.90	$-31.55	$-48.26	$-20.96	$-34.21	$-52.19	$-793.67	$-2.11K	$460.20	$-518.09	$-980.13
Avg Forecast	$0.03	$0.02	$0.02	$0.01	$-0.01	$-0.21	$0.01	$-0.31	$-0.90	$-1.35	$0.90	$0.90	$-2.70	$-3.60	$-8.10	$-5.85	$-10.35	$-4.50	$0.45	$-0.45	$2.25	$-5.40	$-27.00	$-36.00	$-0.80	$-2.43	$3.83	$-1.80	$-0.57	$-1.00
High Forecast	$0.03	$0.02	$0.02	$0.01	$-0.01	$-0.21	$0.01	$-0.31	$-0.90	$-1.35	$0.90	$0.90	$-2.70	$-3.60	$-8.10	$-5.85	$-10.35	$-4.50	$0.45	$-0.45	$2.25	$-5.40	$-27.00	$-36.00	$-0.64	$-1.94	$4.60	$-1.44	$-0.46	$-0.80
Low Forecast	$0.03	$0.02	$0.02	$0.01	$-0.01	$-0.21	$0.01	$-0.31	$-0.90	$-1.35	$0.90	$0.90	$-2.70	$-3.60	$-8.10	$-5.85	$-10.35	$-4.50	$0.45	$-0.45	$2.25	$-5.40	$-27.00	$-36.00	$-0.96	$-2.92	$3.07	$-2.16	$-0.68	$-1.20
Surprise %	-	-	-	-	-	-	-	33.87%	6.92%	-	-	-7.77%	3.71%	1.86%	2.12%	1.18%	1.08%	3.67%	-101.93%	79.78%	-14.02%	8.94%	0.78%	0.95%	65.24%	326.61%	-551.44%	-255.67%	908.93%	980.13%

According to 15 Wall Street analysts, ThermoGenesis's projected average Quarter EPS for Mar 16 is $3.83, with a low estimate of $3.07 and a high estimate of $4.60. This represents a -99.17% decrease compared to THMO previous annual EPS of $460.20 (Dec 15).

ThermoGenesis Peer Comparison by Price Target

Ticker	Company	Last Closing Price	Avg Price Target	Upside/Downside	Avg Rating
RPID	Rapid Micro Biosystems	$1.06	$8.00	654.72%	Hold
BJDX	Bluejay Diagnostics	$4.38	$10.00	128.31%	Buy
HSCS	Heart Test Laboratories	$3.85	$3.00	-22.08%	Buy

THMO Forecast FAQ

What are ThermoGenesis's analysts' financial forecasts?

ThermoGenesis's analysts financial forecasts for the fiscal year (Dec 2023) are as follows: average revenue is $14.07M (high $14.07M, low $14.07M), average EBITDA is $-6.824M (high $-6.738M, low $-6.91M), average net income is $-2.266M (high $-1.982M, low $-2.55M), average SG&A $9.68M (high $9.91M, low $9.45M), and average EPS is $-0.52 (high $-0.52, low $-0.52). THMO's analysts financial forecasts for the fiscal year (Dec 2024) are as follows: average revenue is $16.8M (high $16.8M, low $16.8M), average EBITDA is $-7.85M (high $-7.756M, low $-7.945M), average net income is $-1.281M (high $-968K, low $-1.593M), average SG&A $11.11M (high $11.36M, low $10.85M), and average EPS is $0.08 (high $0.08, low $0.08).

Did the THMO's actual financial results beat the analysts' financial forecasts?

Based on ThermoGenesis's last annual report (Dec 2022), the company's revenue was $10.48M, which missed the average analysts forecast of $17.3M by -39.40%. Apple's EBITDA was $-6.196M, beating the average prediction of $-5.382M by 15.13%. The company's net income was $-11.27M, beating the average estimation of $-2.391M by 371.38%. Apple's SG&A was $7.24M, missing the average forecast of $8.67M by -16.49%. Lastly, the company's EPS was $-20.45, beating the average prediction of $-0.45 by 4444.44%. In terms of the last quarterly report (Mar 2023), ThermoGenesis's revenue was $2.57M, missing the average analysts' forecast of $2.8M by -8.14%. The company's EBITDA was $-1.04M, beating the average prediction of $-429K by 142.66%. ThermoGenesis's net income was $-13.126M, beating the average estimation of $-1.421M by 824.00%. The company's SG&A was $1.84M, beating the average forecast of $1.17M by 57.24%. Lastly, the company's EPS was $-10.5, beating the average prediction of $-0.31 by 3287.10%